Fig. 4From: Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn’s disease: a case reportEsophageal biopsies after treatment that show a normal esophagus without significant alteration on low (left) and high (right) magnificationBack to article page